A combined epidemiologic and metabolomic approach improves CKD prediction

Journal of the American Society of Nephrology

Volumn 24, Issue 8, 2013, Pages 1330-1338

  Rhee, Eugene P ^a,b   Clish, Clary B ^b   Ghorbani, Anahita ^a,c   Larson, Martin G ^c,d   Elmariah, Sammy ^a   McCabe, Elizabeth ^e   Yang, Qiong ^e   Cheng, Susan ^a,c,f   Pierce, Kerry ^b   Deik, Amy ^b   Souza, Amanda L ^b   Farrell, Laurie ^a   Domos, Carly ^a   Yeh, Robert W ^a   Palacios, Igor ^a   Rosenfield, Kenneth ^a   Vasan, Ramachandran S ^c,g   Florez, Jose C ^a   Wang, Thomas J ^h   Fox, Caroline S ^c,f,i   Gerszten, Robert E ^a,b   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d Boston University   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BOSTON MEDICAL CENTER   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; 5 HYDROXYINDOLEACETIC ACID; ACONITIC ACID; ADENOSINE; ALANINE; ALPHA GLYCEROPHOSPHOCHOLINE; ARGININE; CHOLINE; CITRULLINE; CREATININE; INOSITOL; ISOCITRIC ACID; KYNURENIC ACID; NICOTINAMIDE; QUINOLINIC ACID; SERINE; SUCROSE; THREONINE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; XANTHOSINE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DILUTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CIRCULATION; KIDNEY METABOLISM; KIDNEY TUBULE EXCRETION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLOMICS; PRIORITY JOURNAL;

EID: 84879876976     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012101006     Document Type: Article

References (35)

1. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073- 2081, 2010
2. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE: Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21: 1041-1051, 2010
3. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, NakayamaM, Hozawa A, Tsuji I, Ito S, Soga T, Abe T: Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33: 944-952, 2010
4. Toyohara T, Suzuki T, Morimoto R, Akiyama Y, Souma T, Shiwaku HO, Takeuchi Y, Mishima E, Abe M, Tanemoto M, Masuda S, Kawano H, Maemura K, Nakayama M, Sato H, Mikkaichi T, Yamaguchi H, Fukui S, Fukumoto Y, Shimokawa H, Inui K, Terasaki T, Goto J, Ito S, Hishinuma T, Rubera I, Tauc M, Fujii-Kuriyama Y, Yabuuchi H, Moriyama Y, Soga T, Abe T: SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol 20: 2546- 2555, 2009
5. Wang TJ, LarsonMG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453, 2011
6. Dhanakoti SN, Brosnan JT, Herzberg GR, Brosnan ME: Renal arginine synthesis: studies in vitro and in vivo. Am J Physiol 259: E437-E442, 1990
7. van de Poll MC, Soeters PB, Deutz NE, Fearon KC, Dejong CH: Renal metabolism of amino acids: Its role in interorgan amino acid exchange. Am J Clin Nutr 79: 185-197, 2004
8. Zablocki K, Miller SP, Garcia-Perez A, Burg MB: Accumulation of glycerophosphocholine (GPC) by renal cells:Osmotic regulation ofGPC:choline phosphodiesterase. Proc Natl Acad Sci U S A 88: 7820-7824, 1991
9. Li Z, Vance DE: Phosphatidylcholine and choline homeostasis. J Lipid Res 49: 1187-1194, 2008
10. Levey AS, Perrone RD, MadiasNE: Serumcreatinine and renal function. Annu Rev Med 39: 465-490, 1988
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
12. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease EpidemiologyCollaboration):Anewequation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
14. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKDEPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
15. Owen EE, Robinson RR: Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride. J Clin Invest 42: 263-276, 1963
16. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C: Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.JClin Invest 65: 1162-1173, 1980
17. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992
18. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J AmSocNephrol 17: 17- 25, 2006
19. Wirthensohn G, Guder WG: Renal substrate metabolism. Physiol Rev 66: 469-497, 1986
20. Miller B, SchmidH, Chen TJ, Schmolke M, GuderWG: Determination of choline dehydrogenase activity along the rat nephron. Biol Chem Hoppe Seyler 377: 129-137, 1996
21. Levillain O, Hus-Citharel A, Morel F, Bankir L: Localization of arginine synthesis along rat nephron. Am J Physiol 259: F916-923, 1990
22. O'Donoghue N, Sweeney T, Donagh R, Clarke KJ, Porter RK: Control of choline oxidation in rat kidney mitochondria. Biochim Biophys Acta 1787: 1135-1139, 2009
23. Koepsell H, Endou H: The SLC22 drug transporter family. Pflugers Arch 447: 666-676, 2004
24. Uwai Y, HonjoH, Iwamoto K: Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOA T3. Pharmacol Res 65: 254-260, 2012
25. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63, 2011
26. MurrayMF: The human indoleamine 2, 3-dioxygenase gene and related human genes. Curr Drug Metab 8: 197-200, 2007
27. Mohib K, Wang S, Guan Q, Mellor AL, Sun H, Du C, Jevnikar AM: Indoleamine 2, 3-dioxygenase expression promotes renal ischemiareperfusion injury. Am J Physiol Renal Physiol 295: F226-F234, 2008
28. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez-Cardona JA, Pruitt IE, Rhee EP, Colvin RA, Gerszten RE: Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem284: 19189-19195, 2009
29. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF Jr, Hunt NH, Stocker R: Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16: 279-285, 2010
30. Sato E, Kohno M, Yamamoto M, Fujisawa T, Fujiwara K, Tanaka N: Metabolomic analysis of human plasma from haemodialysis patients. Eur J Clin Invest 41: 241-255, 2011
31. Goek ON, Döring A, Gieger C, Heier M, Koenig W, Prehn C, Römisch-Margl W, Wang-Sattler R, Illig T, Suhre K, Sekula P, Zhai G, Adamski J, Köttgen A, Meisinger C: Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 60: 197-206, 2012
32. Shah VO, Townsend RR, Feldman HI, Pappan KL, Kensicki E, Vander Jagt DL: Plasmametabolomic profiles in different stages of CKD. Clin J Am Soc Nephrol 8: 363-370, 2012
33. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110: 281-290, 1979
34. FoxCS, LarsonMG, Leip EP, Culleton B, Wilson PW, LevyD: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004
35. Rhee EP, Cheng S, LarsonMG, WalfordGA, LewisGD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE: Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411, 2011